Anifrolumab May Reduce Skin Disease Severity in Patients With Active Systemic Lupus Erythematosus
Researchers evaluated the effect on skin-specific systemic lupus erythematosus disease activity using data pooled from the TULIP-1 and TULIP-2 trials.
All articles by Heidi W. Moore
Do TNFis Reduce the Risk for Progression to PsA in Patients With Psoriasis?
Researchers evaluated the use of TNFis vs methotrexate in reducing the risk for progression to psoriatic arthritis in patients with psoriasis.
Secukinumab Improves Nail Psoriasis, Inhibition of Radiographic Progression in Psoriatic Arthritis
Researchers reported on the efficacy of secukinumab in patients with psoriatic arthritis and nail psoriasis and other elements of the disease, including radiographic progression.
-
Loading...
-
Loading...
Next post in In-Depth Focus from ACR 2019: SpA
